APPLICATION OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODELLING FOR PREDICTION OF CYP-MEDIATED DRUG-DRUG INTERACTIONS (DDIs) INVOLVING ETHINYLESTRADIOL (EE)